Parkwood LLC Maintains Stake in Mylan N.V. (MYL)

Parkwood LLC continued to hold its stake in shares of Mylan N.V. (NASDAQ:MYL) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,600 shares of the company’s stock at the end of the second quarter. Parkwood LLC’s holdings in Mylan N.V. were worth $528,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Wellington Management Group LLP increased its position in shares of Mylan N.V. by 2.6% in the first quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock valued at $1,808,088,000 after buying an additional 1,165,852 shares in the last quarter. BlackRock Inc. increased its position in shares of Mylan N.V. by 3,447.5% in the first quarter. BlackRock Inc. now owns 38,822,643 shares of the company’s stock valued at $1,513,696,000 after buying an additional 37,728,274 shares during the period. Vanguard Group Inc. increased its position in shares of Mylan N.V. by 3.9% in the first quarter. Vanguard Group Inc. now owns 29,348,816 shares of the company’s stock valued at $1,144,310,000 after buying an additional 1,090,791 shares during the period. State Street Corp increased its position in shares of Mylan N.V. by 1.2% in the first quarter. State Street Corp now owns 20,176,564 shares of the company’s stock valued at $786,700,000 after buying an additional 234,521 shares during the period. Finally, Pzena Investment Management LLC bought a new position in shares of Mylan N.V. during the first quarter valued at about $283,158,000. Institutional investors and hedge funds own 71.57% of the company’s stock.

Mylan N.V. (NASDAQ:MYL) traded up 0.52% on Friday, reaching $30.72. 7,185,271 shares of the company traded hands. The stock’s 50-day moving average is $36.12 and its 200-day moving average is $38.80. Mylan N.V. has a 1-year low of $29.39 and a 1-year high of $49.09. The stock has a market capitalization of $16.47 billion, a price-to-earnings ratio of 24.83 and a beta of 1.27.

Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.18 by $0.08. The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The company’s revenue was up 15.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.16 EPS. Equities research analysts expect that Mylan N.V. will post $4.52 EPS for the current year.

WARNING: This news story was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.com-unik.info/2017/08/19/parkwood-llc-holds-position-in-mylan-myl-updated-updated.html.

Several brokerages have recently issued reports on MYL. BidaskClub cut shares of Mylan N.V. from a “sell” rating to a “strong sell” rating in a research report on Wednesday. Citigroup Inc. raised shares of Mylan N.V. from a “neutral” rating to a “buy” rating and upped their price target for the company from $36.00 to $42.00 in a research report on Wednesday. UBS AG reaffirmed a “buy” rating and set a $46.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday, August 10th. BMO Capital Markets reaffirmed an “outperform” rating and set a $45.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday, August 10th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $32.00 price objective (down previously from $33.00) on shares of Mylan N.V. in a research report on Thursday, August 10th. Two analysts have rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Mylan N.V. presently has an average rating of “Buy” and an average target price of $47.73.

In other Mylan N.V. news, insider Anthony Mauro sold 10,000 shares of the company’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $400,000.00. Following the transaction, the insider now owns 140,653 shares of the company’s stock, valued at $5,626,120. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, President Rajiv Malik sold 25,000 shares of the company’s stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the completion of the transaction, the president now directly owns 799,855 shares in the company, valued at approximately $31,994,200. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

What are top analysts saying about Mylan N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mylan N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit